Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 77 results:
Author [ Title] Type Year Filters: Author is Doulberis, Michael [Clear All Filters]
Vitamin D Deficiency and Unclear Abdominal Pain in Patients from Low- and Middle-Income Countries..
Int J Environ Res Public Health. 16(23),
(2019). Update on the association between non-alcoholic fatty liver disease and Helicobacter pylori infection..
Int J Clin Pract. e13737.
(2020). Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial..
Medicina (Kaunas). 56(7),
(2020). The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis..
Neurochem Int. 144, 104938.
(2021). Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents..
Expert Opin Pharmacother. 21(3), 247-251.
(2020). Selenoprotein P in Patients with Nonalcoholic Fatty Liver Disease..
Exp Clin Endocrinol Diabetes.
(2019). Role of autophagy in gastric carcinogenesis..
World J Gastrointest Oncol. 13(10), 1244-1262.
(2021). Rodent models of obesity..
Minerva Endocrinol. 45(3), 243-263.
(2020). Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?.
Helicobacter. 23(1),
(2018). Response to letter to the editor of Carcinogenesis by Li et al., 2020..
Carcinogenesis. 41(4), 539-540.
(2020). The relationship between -related microbiota dysbiosis and gastrointestinal tract pathologies..
Scand J Gastroenterol. 1-2.
(2019). Potential impact of trained innate immunity on the pathophysiology of metabolic dysfunction-associated fatty liver disease..
Clin Immunol. 256, 109776.
(2023). A potential impact of Helicobacter pylori-related sarcopenia on severity of portal hypertension..
Liver Int.
(2021). Potential impact of Helicobacter pylori-related metabolic syndrome on arterial hypertension outcomes..
Am J Hypertens.
(2022). A potential impact of Helicobacter pylori-related metabolic syndrome on early and long-term outcomes of bariatric surgery..
Gastrointest Endosc. 96(6), 1088-1089.
(2022). Potential impact of Helicobacter pylori-related metabolic syndrome and Galectin-3 on liver, chronic kidney and brain disorders..
Metabolism. 154736.
(2021). Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis..
Metabolism. 87, 18-24.
(2018). Potential impact of Helicobacter pylori-related Galectin-3 on chronic kidney, cardiovascular and brain disorders in decompensated cirrhosis..
Dig Liver Dis. 52(1), 121-123.
(2020). A potential impact of Helicobacter pylori-related galectin-3 in neurodegeneration..
Neurochem Int. 113, 137-151.
(2018). Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology..
Dig Dis Sci. 63(4), 1087-1088.
(2018). Potential Impact of Helicobacter pylori Infection on Reflux Disease Sequence: Illuminating the Gap..
J Clin Gastroenterol. 54(2), 200-201.
(2020). Potential Impact of Helicobacter pylori Infection on Pancreatic Cancer Pathophysiology..
J Gastrointest Cancer.
(2022). Potential impact of Helicobacter pylori infection on hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B..
J Viral Hepat.
(2023).
(2022).
(2018).